Terina N. Martinez, PhD
Dr. Terina N. Martinez is Executive Director of the Duchenne Regulatory Science Consortium (D-RSC) and the Critical Path to Therapeutics for the Ataxias (CPTA) at C-Path. Terina is a highly motivated neuroscientist with experience in science communication, research program management and leadership, biomarker and drug development in neurodegenerative diseases across diverse sectors including academia, industry, nonprofit foundations and patient advocacy groups.
Prior to joining C-Path, Terina was a Senior Associate Director, Research Programs at The Michael J. Fox Foundation for Parkinson’s Research in New York where she led the Foundation’s programs for preclinical tools and animal models, emerging targets and inflammation. Thereafter, Terina was a field application and collaboration scientist with Taconic Biosciences based out of Cambridge, MA, where she provided expert technical and scientific consultation across all research sectors for preclinical model selection, application, translational and IND-enabling study design, encompassing diverse disease and therapeutic areas.
Terina received her undergraduate degree in biology from the University of Dallas and earned a Ph.D. in integrative biology from the University of Texas Southwestern Medical Center at Dallas, where she studied cellular and molecular neuroscience. She completed her postdoctoral training at the University of Pittsburgh.
Terina is passionate about improving the lives of people living with devastating neurodegenerative disease and is thrilled to lead the D-RSC and CPTA teams in executing C-Path’s mission to develop new approaches to advance medical innovation and regulatory science.